Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanna Witting

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Neurology|February 18, 2020
Physical activity in myotonic dystrophy type 1Kirsten Lykke Knak, Aisha Munawar Sheikh, Nanna Witting, et al.
Journal of Rehabilitation Medicine|March 30, 2017
Reliability of the 2- and 6-minute walk tests in neuromuscular diseasesKirsten Lykke Knak, Linda Kahr Andersen, Nanna Witting, et al.
Pain|December 22, 2005
A PET activation study of brush-evoked allodynia in patients with nerve injury painNanna Witting, Ron C Kupers, Peter Svensson, et al.
International Journal of Cardiology|January 2, 2013
Response letter to "Cardiac involvement in myotonic dystrophy type 1--do not forget the loop recorder!"Helle Petri, John Vissing, Nanna Witting, et al.
Annals of Clinical and Translational Neurology|July 17, 2020
Responsiveness of outcome measures in myotonic dystrophy type 1Kirsten L Knak, Aisha M Sheikh, Nanna Witting, et al.
Neuromuscular Disorders : NMD|October 25, 2018
Role of neuronal nitric oxide synthase (nNOS) in Duchenne and Becker muscular dystrophies - Still a possible treatment modality?Nanna W Dombernowsky, Joakim N E Ölmestig, Nanna Witting, et al.
Brain : a Journal of Neurology|October 21, 2017
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized studyGrete Andersen, Gitte Hedermann, Nanna Witting, et al.
Neurology|May 28, 2020
Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1Kirsten L Knak, Aisha M Sheikh, Henning Andersen, et al.
Neuromuscular Disorders : NMD|February 11, 2014
Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathyGülsenay Citirak, Nanna Witting, Morten Duno, et al.
Neuromuscular Disorders : NMD|August 27, 2024
Ocular versus generalized myasthenia gravis: a continuum associated with acetylcholine receptor antibody titersKasper Holst Axelsen, Rebecca Kjær Andersen, Linda Kahr Andersen, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Neurology|February 18, 2020
Physical activity in myotonic dystrophy type 1Kirsten Lykke Knak, Aisha Munawar Sheikh, Nanna Witting, et al.
Journal of Rehabilitation Medicine|March 30, 2017
Reliability of the 2- and 6-minute walk tests in neuromuscular diseasesKirsten Lykke Knak, Linda Kahr Andersen, Nanna Witting, et al.
Pain|December 22, 2005
A PET activation study of brush-evoked allodynia in patients with nerve injury painNanna Witting, Ron C Kupers, Peter Svensson, et al.
International Journal of Cardiology|January 2, 2013
Response letter to "Cardiac involvement in myotonic dystrophy type 1--do not forget the loop recorder!"Helle Petri, John Vissing, Nanna Witting, et al.
Annals of Clinical and Translational Neurology|July 17, 2020
Responsiveness of outcome measures in myotonic dystrophy type 1Kirsten L Knak, Aisha M Sheikh, Nanna Witting, et al.
Neuromuscular Disorders : NMD|October 25, 2018
Role of neuronal nitric oxide synthase (nNOS) in Duchenne and Becker muscular dystrophies - Still a possible treatment modality?Nanna W Dombernowsky, Joakim N E Ölmestig, Nanna Witting, et al.
Brain : a Journal of Neurology|October 21, 2017
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized studyGrete Andersen, Gitte Hedermann, Nanna Witting, et al.
Neurology|May 28, 2020
Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1Kirsten L Knak, Aisha M Sheikh, Henning Andersen, et al.
Neuromuscular Disorders : NMD|February 11, 2014
Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathyGülsenay Citirak, Nanna Witting, Morten Duno, et al.
Neuromuscular Disorders : NMD|August 27, 2024
Ocular versus generalized myasthenia gravis: a continuum associated with acetylcholine receptor antibody titersKasper Holst Axelsen, Rebecca Kjær Andersen, Linda Kahr Andersen, et al.
Pageof 8